{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T05:08:42Z","timestamp":1789276122594,"version":"build-2803163510"},"reference-count":12,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:00:00Z","timestamp":1761523200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014976","name":"Liverpool School of Tropical Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014976","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008897","name":"Janssen Pharmaceuticals Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["INV-040482"],"award-info":[{"award-number":["INV-040482"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["INV-040484"],"award-info":[{"award-number":["INV-040484"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009660","name":"London School of Hygiene and Tropical Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009660","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001322","name":"South African Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"UK Research and Innovation Medical Research Council","doi-asserted-by":"publisher","award":["IAA21127"],"award-info":[{"award-number":["IAA21127"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"UK Research and Innovation Medical Research Council","doi-asserted-by":"publisher","award":["IAA21126"],"award-info":[{"award-number":["IAA21126"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Microbiology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.tim.2025.10.010","type":"journal-article","created":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T12:19:35Z","timestamp":1762431575000},"page":"31-33","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["PurFect timing: revisiting purine metabolism for tuberculosis treatment"],"prefix":"10.1016","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3487-3187","authenticated-orcid":false,"given":"Richard J.","family":"Wall","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie","family":"Mizrahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk A.","family":"Lamprecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tim.2025.10.010_bb0005","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1021\/acsinfecdis.6b00102","article-title":"The inosine monophosphate dehydrogenase, GuaB2, is a vulnerable new bactericidal drug target for tuberculosis","volume":"3","author":"Singh","year":"2017","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.tim.2025.10.010_bb0010","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1021\/acsinfecdis.6b00103","article-title":"Essential but not vulnerable: indazole sulfonamides targeting inosine monophosphate dehydrogenase as potential leads against Mycobacterium tuberculosis","volume":"3","author":"Park","year":"2017","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.tim.2025.10.010_bb0015","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1021\/acsinfecdis.6b00185","article-title":"The bare essentials of antibiotic target validation","volume":"3","author":"Hedstrom","year":"2017","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.tim.2025.10.010_bb0020","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/s41586-025-09177-7","article-title":"Targeting de novo purine biosynthesis for tuberculosis treatment","volume":"644","author":"Lamprecht","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.tim.2025.10.010_bb0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1011663","article-title":"Transposon sequencing reveals metabolic pathways essential for Mycobacterium tuberculosis infection","volume":"20","author":"Block","year":"2024","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.tim.2025.10.010_bb0030","doi-asserted-by":"crossref","first-page":"5571","DOI":"10.1111\/febs.16448","article-title":"The mycobacterial guaB1 gene encodes a guanosine 5'-monophosphate reductase with a cystathionine-\u03b2-synthase domain","volume":"289","author":"Knejzl\u00edk","year":"2022","journal-title":"FEBS J."},{"key":"10.1016\/j.tim.2025.10.010_bb0035","doi-asserted-by":"crossref","first-page":"6673","DOI":"10.1038\/s41467-024-50933-6","article-title":"Deciphering the allosteric regulation of mycobacterial inosine-5\u2032-monophosphate dehydrogenase","volume":"15","author":"Bulvas","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tim.2025.10.010_bb0040","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.pep.2009.04.001","article-title":"Hypoxanthine\u2013guanine phosphoribosyltransferase from Mycobacterium tuberculosis H37Rv: cloning, expression, and biochemical characterization","volume":"66","author":"Biazus","year":"2009","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.tim.2025.10.010_bb0045","doi-asserted-by":"crossref","DOI":"10.1128\/mSystems.00070-19","article-title":"Genomewide assessment of Mycobacterium tuberculosis conditionally essential metabolic pathways","volume":"4","author":"Minato","year":"2019","journal-title":"mSystems"},{"key":"10.1016\/j.tim.2025.10.010_bb0050","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.00897-24","article-title":"Discovery of GuaB inhibitors with efficacy against Acinetobacter baumannii infection","volume":"15","author":"Kofoed","year":"2024","journal-title":"mBio"},{"key":"10.1016\/j.tim.2025.10.010_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2024.130026","article-title":"Discovery of potent dihydro-oxazinoquinolinone inhibitors of GuaB for the treatment of tuberculosis","volume":"117","author":"Zhou","year":"2025","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.tim.2025.10.010_bb0060","doi-asserted-by":"crossref","first-page":"4483","DOI":"10.1021\/acs.jmedchem.9b00020","article-title":"Structure-guided drug design of 6-substituted adenosine analogues as potent inhibitors of Mycobacterium tuberculosis adenosine kinase","volume":"62","author":"Crespo","year":"2019","journal-title":"J. Med. Chem."}],"container-title":["Trends in Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966842X25003038?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966842X25003038?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T19:36:39Z","timestamp":1786217799000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0966842X25003038"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":12,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S0966842X25003038"],"URL":"https:\/\/doi.org\/10.1016\/j.tim.2025.10.010","relation":{},"ISSN":["0966-842X"],"issn-type":[{"value":"0966-842X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PurFect timing: revisiting purine metabolism for tuberculosis treatment","name":"articletitle","label":"Article Title"},{"value":"Trends in Microbiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tim.2025.10.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}